OPKO Health Current Ratio 2010-2024 | OPK
OPKO Health current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| OPKO Health Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-03-31 | $0.39B | $0.20B | 1.92 |
| 2023-12-31 | $0.31B | $0.20B | 1.55 |
| 2023-09-30 | $0.36B | $0.20B | 1.78 |
| 2023-06-30 | $0.43B | $0.23B | 1.92 |
| 2023-03-31 | $0.41B | $0.22B | 1.83 |
| 2022-12-31 | $0.40B | $0.21B | 1.85 |
| 2022-09-30 | $0.41B | $0.27B | 1.55 |
| 2022-06-30 | $0.50B | $0.22B | 2.30 |
| 2022-03-31 | $0.75B | $0.31B | 2.44 |
| 2021-12-31 | $0.82B | $0.33B | 2.49 |
| 2021-09-30 | $0.56B | $0.28B | 1.97 |
| 2021-06-30 | $0.55B | $0.30B | 1.80 |
| 2021-03-31 | $0.60B | $0.40B | 1.48 |
| 2020-12-31 | $0.52B | $0.38B | 1.39 |
| 2020-09-30 | $0.43B | $0.34B | 1.28 |
| 2020-06-30 | $0.36B | $0.28B | 1.29 |
| 2020-03-31 | $0.27B | $0.25B | 1.12 |
| 2019-12-31 | $0.32B | $0.25B | 1.30 |
| 2019-09-30 | $0.29B | $0.27B | 1.08 |
| 2019-06-30 | $0.34B | $0.28B | 1.22 |
| 2019-03-31 | $0.44B | $0.40B | 1.10 |
| 2018-12-31 | $0.32B | $0.29B | 1.10 |
| 2018-09-30 | $0.29B | $0.32B | 0.91 |
| 2018-06-30 | $0.32B | $0.31B | 1.05 |
| 2018-03-31 | $0.35B | $0.32B | 1.10 |
| 2017-12-31 | $0.35B | $0.31B | 1.12 |
| 2017-09-30 | $0.43B | $0.26B | 1.66 |
| 2017-06-30 | $0.47B | $0.28B | 1.67 |
| 2017-03-31 | $0.46B | $0.27B | 1.74 |
| 2016-12-31 | $0.48B | $0.26B | 1.84 |
| 2016-09-30 | $0.50B | $0.26B | 1.97 |
| 2016-06-30 | $0.51B | $0.28B | 1.80 |
| 2016-03-31 | $0.45B | $0.27B | 1.70 |
| 2015-12-31 | $0.45B | $0.25B | 1.80 |
| 2015-09-30 | $0.52B | $0.36B | 1.45 |
| 2015-06-30 | $0.28B | $0.18B | 1.54 |
| 2015-03-31 | $0.39B | $0.18B | 2.16 |
| 2014-12-31 | $0.14B | $0.08B | 1.72 |
| 2014-09-30 | $0.16B | $0.08B | 2.12 |
| 2014-06-30 | $0.18B | $0.08B | 2.31 |
| 2014-03-31 | $0.21B | $0.09B | 2.43 |
| 2013-12-31 | $0.24B | $0.09B | 2.64 |
| 2013-09-30 | $0.24B | $0.07B | 3.38 |
| 2013-06-30 | $0.23B | $0.06B | 3.87 |
| 2013-03-31 | $0.24B | $0.06B | 4.08 |
| 2012-12-31 | $0.08B | $0.05B | 1.50 |
| 2012-09-30 | $0.09B | $0.05B | 1.90 |
| 2012-06-30 | $0.09B | $0.03B | 2.91 |
| 2012-03-31 | $0.10B | $0.03B | 3.35 |
| 2011-12-31 | $0.10B | $0.02B | 5.30 |
| 2011-09-30 | $0.12B | $0.02B | 5.81 |
| 2011-06-30 | $0.13B | $0.02B | 5.93 |
| 2011-03-31 | $0.14B | $0.03B | 5.79 |
| 2010-12-31 | $0.06B | $0.03B | 2.08 |
| 2010-09-30 | $0.05B | $0.02B | 2.21 |
| 2010-06-30 | $0.05B | $0.02B | 2.70 |
| 2010-03-31 | $0.06B | $0.03B | 2.10 |
| 2009-12-31 | $0.06B | $0.01B | 4.90 |
| 2009-09-30 | $0.07B | $0.00B | 16.52 |
| 2009-06-30 | $0.05B | $0.01B | 7.92 |
| 2009-03-31 | $0.01B | $0.01B | 0.88 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.878B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $220.605B | 26.73 |
| Intuitive Surgical (ISRG) | United States | $136.719B | 82.36 |
| Edwards Lifesciences (EW) | United States | $52.679B | 34.28 |
| DexCom (DXCM) | United States | $50.959B | 77.19 |
| IQVIA Holdings (IQV) | United States | $41.760B | 24.23 |
| IDEXX Laboratories (IDXX) | United States | $41.361B | 48.48 |
| Alcon (ALC) | Switzerland | $40.168B | 29.62 |
| STERIS (STE) | Ireland | $22.331B | 26.10 |
| Waters (WAT) | United States | $19.956B | 29.33 |
| Hologic (HOLX) | United States | $17.678B | 19.78 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.647B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.410B | 77.23 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.253B | 14.30 |
| Sysmex ADR (SSMXY) | Japan | $10.794B | 33.85 |
| Teleflex (TFX) | United States | $9.642B | 15.01 |
| Globus Medical (GMED) | United States | $8.713B | 25.54 |
| Penumbra (PEN) | United States | $8.117B | 92.25 |
| Masimo (MASI) | United States | $6.591B | 37.97 |
| Glaukos (GKOS) | United States | $5.421B | 0.00 |
| TransMedics (TMDX) | United States | $4.241B | 402.41 |
| Integer Holdings (ITGR) | United States | $3.827B | 23.12 |
| LivaNova (LIVN) | United Kingdom | $3.355B | 19.92 |
| PROCEPT BioRobotics (PRCT) | United States | $3.240B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.845B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.744B | 18.83 |
| Inari Medical (NARI) | United States | $2.470B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.449B | 20.72 |
| RxSight (RXST) | United States | $2.272B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.994B | 8.69 |
| Alphatec Holdings (ATEC) | United States | $1.586B | 0.00 |
| Veracyte (VCYT) | United States | $1.577B | 0.00 |
| Artivion (AORT) | United States | $0.977B | 93.60 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.894B | 17.38 |
| Silk Road Medical (SILK) | United States | $0.805B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.798B | 0.00 |
| Paragon 28 (FNA) | United States | $0.684B | 0.00 |
| SiBone (SIBN) | United States | $0.640B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.632B | 21.45 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.542B | 0.00 |
| IRadimed (IRMD) | United States | $0.541B | 30.28 |
| Pacific Biosciences Of California (PACB) | United States | $0.468B | 0.00 |
| Nevro (NVRO) | United States | $0.386B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.384B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.334B | 11.42 |
| Sight Sciences (SGHT) | United States | $0.277B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.275B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.262B | 0.00 |
| AxoGen (AXGN) | United States | $0.261B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.245B | 0.00 |
| NeuroPace (NPCE) | United States | $0.229B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.212B | 0.00 |
| Inogen (INGN) | United States | $0.205B | 0.00 |
| 908 Devices (MASS) | United States | $0.199B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.172B | 0.00 |
| Accuray (ARAY) | United States | $0.168B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.168B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.162B | 8.23 |
| CVRx (CVRX) | United States | $0.158B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.154B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.100B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| Neuronetics (STIM) | United States | $0.075B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Envoy Medical (COCH) | United States | $0.066B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.063B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.062B | 13.14 |
| Monogram Orthopaedics (MGRM) | United States | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.057B | 0.00 |
| InspireMD (NSPR) | Israel | $0.052B | 0.00 |
| DarioHealth (DRIO) | United States | $0.049B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.044B | 0.00 |
| LENSAR (LNSR) | United States | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.029B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.026B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| PAVmed (PAVM) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.018B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |